And some say there is no corruption involving the fda!!!

New Post Public Reply Private Reply Replies (2) Message Board
HCIT
585
And some say there is no corruption involving the fda!!! Take a look at this link to shine a little more light on their corruption and then say what you want. This is totally directed at those who say I do not know what I am saying and have said for almost 2 years here - GLTA

https://www.seattleorganicrestaurants.com/veg...safety.php

New Harvard study reveals Institutional Corruption of Pharmaceuticals and how FDA cannot be trusted with public safety

A new article with title of “Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs" is set to be published in the Journal of Law, Medicine and Ethics (JLME). The article written by Prof. Donald W. Light, Joel Lexchin, and Jonathan J. Darrow present evidence that about 90% of all new drugs approved by FDA over the last 30 years have little or no advantages compared to the existing drugs.

The article points out how FDA who supposedly must be in charge of public health and safety is nothing more than a puppet ran by giant pharmaceutical and drug companies. The fact is that the medical industry has become a leading cause of death and just in US, annually, 12,000 people die due to unnecessary surgeries, 7,000 people die due to medical errors, 20,000 people die due to other errors, 80,000 people die from infections acquired at the hospitals and 106,000 people die from adverse side effect of medications.

FDA-Big-Pharma-Harvard-drugs
According to Harvard report, in US alone, every week, about 53,000 people end up in hospitals and 2400 people die as a result of taking prescription drugs:

The Harvard report points out how one in five drugs approved by FDA seriously harm people and prescription drugs are becoming the 4th leading cause of death. There are also other related issues with drugs such as hospitalizations from over-dosing, errors, or recreational drug use and about 80 million people a year suffer from mild side effects of drugs like insomnia, dizziness, aches and digestive problems.

The forthcoming article in JLME also shows that the pharmaceutical industry makes large contribution to FDA for reviewing its drugs and also contributes large campaign donations to US Congress in order to pass legislation that would benefit the giant Pharmaceuticals. According to the authors “Congress has underfunded FDA enforcement capacities since 1906, and turning to industry-paid “user fees” since 1992 has biased funding to limit the FDA’s ability to protect the public from serious adverse reactions to drugs that have few offsetting advantages”.
Biotech, Pharmaceutical and chemical companies spend more money selling and promoting a product or a drug rather than scientific research and studies about the safety of their products:

With FDA’s incompetence and failure to take a stand and act based on public's interests and safety, consumers and patients are now turning into innocent victims in mercy of giant biotech, chemical and pharmaceutical companies. In fact, in order to get FDA’s approval and buy public trust, the giant pharmaceuticals fund a team of doctors and researchers to publish a literature in one of the scientific journals to hide the drug’s side effect and overstate its benefits.

On the other hand, FDA who gets paid by giant pharmaceuticals spare no efforts to perform any independent studies of its own and totally relies on the information that’s presented to them by giant pharmaceuticals or biotech companies. Since such corrupted knowledge is approved and regulated by FDA, even sometimes good physicians recommend these toxic drugs or products to their patients.

institutional-corruption-of-pharmaceuticals-how-FDA-cannot-be-trusted
Giant Pharmaceuticals, biotech (Monsanto and DuPont), and chemical companies (Dow, Bayer, and ExxonMobil) are growing even bigger under the protection of FDA:

According to Harvard article, “The New England Journal of Medicine has published, without comment, proposals by two senior figures from the FDA to loosen criteria drugs that allege to prevent Alzheimer’s disease by treating it at an early stage. First, they use the word “disease” to refer to a hypothetical “early-stage Alzheimer’s disease” that supposedly exists “before the earliest symptoms of Alzheimer’s disease are apparent.” The proposed looser criteria would legitimate drugs as “safe and effective” that have little or no evidence of being effective and expose millions to risks of harmful side effects”.
How conflict of interest has become a defining problem in the modern science:

Not long ago, Monsanto’s former researcher, Richard Goodman was chosen in position of the associate editor of the journal for biotechnology after the famous Séralini study showed huge tumors in rats as a result of Monsanto’s GM maize and Roundup. The biotech companies have unleashed genetically modified organisms that have been linked to a wide range of diseases including cancer, birth defects, gluten diseases and allergies in our food supply.

Two major GMO labeling movements, both in Washington and California were defeated since the junk food, biotech and chemical companies poured millions of dollars to defeat a label GMO labeling: http://www.seattleorganicrestaurants.com/vega...iative.php

These days, majority of big donations to our schools and universities come from giant Pharmaceutical, biotech, chemical and oil companies. You would think that at least the academic research are non-biased and natural, considering that our government is deeply in bed with giant oil, drug, biotech, chemical and pharmaceutical companies.

The question is that are we that naive to think that billions of dollars of contributions from these giant companies (who are polluting our food, air and environment), won’t tilt or at least steer the findings of these so called ‘scientific studies?’

Resources:

http://www.ethics.harvard.edu/lab/blog/312-ri...y-informed

http://therefusers.com/refusers-newsroom/inst...rjXa7RIXIV

http://www.ethics.harvard.edu/lab/featured/347-jlmeissue

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
https://media.gettyimages.com/photos/the-grea...wdoE_swYM=
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WellLink Advisory Board Eyes Future of Healthcare Innovation

Updated Category News Views 3

Strategic Collaboration for Healthcare Evolution Ready to shake things up in healthcare, WellLink is setting the stage with its brand new Advisory Board. This move isn’t just about having fancy titles sitting around a conference table — it's about grabbing onto the future with both hands and figuring out just what the heck the healthcare industry needs next....

Continue Reading
G-STAR & Wu-Tang Clan Unleash Denim Fusion

Updated Category News Views 5

Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...

Continue Reading
TWP & Commbi Unveil Exclusive Pony Clog Collaboration

Updated Category News Views 5

A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...

Continue Reading
Perk's U.S. Expansion: A Bold Move in Spend Control

Updated Category News Views 5

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...

Continue Reading
BMAP Expands: Bridging Borders in Legal Advocacy

Updated Category News Views 4

Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...

Continue Reading
NY Sheriffs' Court Battle: Immigration Policies Under Fire

Updated Category News Views 5

Sheriffs Clash with State Over Immigration Policies In a tense showdown reminiscent of an old-time standoff, 15 New York county sheriffs have drawn their battle lines against the state’s capricious maneuvers by pushing a federal court to hit the brakes on Albany’s newly minted immigration rule. The so-called “Local Cops, Local Crimes Act” is catching serious heat,...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 6

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
Feeding Families Foundation Gains $121,500 for NYC Push

Updated Category News Views 5

Holy smokes, here comes some good news in the nonprofit corners! Feeding Families Foundation just got a hefty $121,500 boost from the Association of Contracting Plumbers of the City of New York Inc. This ain't just some pocket change; it's a full-fledged lifeline that helps them keep on delivering meals to parents who are practically living at their kid’s hospital...

Continue Reading
Orthopedic Expert Highlighting Midwest Pain Access Gaps

Updated Category News Views 5

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

Continue Reading
Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 6

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading

Top 5 Most Recently Viewed Articles

Mullen Automotive Faces Securities Fraud Lawsuit Opportunities

Updated Category News Views 276

Mullen Automotive Securities Fraud Lawsuit Overview Mullen Automotive, Inc. (NASDAQ: MULN) is currently facing significant legal scrutiny as investors step forward to address alleged discrepancies in information provided by the company. This situation presents both challenges and opportunities for investors who purchased securities during a specified period. What...

Continue Reading
Microsoft and OpenAI: Navigating a Complex Financial Partnership

Updated Category News Views 256

Understanding the Microsoft and OpenAI Valuation Dynamics OpenAI and Microsoft Corp MSFT are currently engaged in critical negotiations to convert Microsoft's noteworthy $14 billion investment into shares within OpenAI. This transition illustrates the evolving landscape of investment in artificial intelligence. The Impact of OpenAI's Valuation on Negotiations Recen

Continue Reading
Legal Battle Between CrowdStrike and Delta Over Flight Issues

Updated Category News Views 264

CrowdStrike and Delta Engage in Legal Dispute In a significant legal battle, CrowdStrike (NASDAQ: CRWD), a well-known cybersecurity firm, has initiated a lawsuit against Delta Air Lines (NYSE: DAL). This action comes in response to a major incident stemming from a faulty software update that caused extensive flight disruptions globally. The lawsuit was filed in U.S....

Continue Reading
Apranga Group Reports Impressive Growth in Retail Turnover

Updated Category News Views 54

Apranga Group rolled out some impressive numbers back in September 2024, reporting a retail turnover of EUR 28.5 million. That marked a solid increase of 6.5% compared to the same month last year, showing the group's hustle to bolster its market presence. But here’s where things get spicy: while Lithuania showed decent growth at 6.3%, Latvia shot up with a staggering...

Continue Reading
ePayPolicy Celebrates Continued Growth with Inc. 5000 Recognition

Updated Category News Views 164

ePayPolicy Achieves Recognition on Inc. 5000 List ePayPolicy has once again made a mark by securing the No. 1759 spot on this year's Inc. 5000 list, an esteemed recognition celebrating the fastest-growing private companies in the United States. This achievement highlights the company's consistent dedication and the expanding reach of its insurance payments platform....

Continue Reading